Back to Insider Trading View Full Company Profile

ADPT

UNKNOWN

Adaptive Biotechnologies Corp

CIK: 0001478320

Strong Sell (90% confidence)

Last activity: Yesterday

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$59.50M

Insider Roster (9 total, 9 active)

Insider Buys Sells Net Value Holdings
ROBINS CHAD M
CEO and Chairman
0 8 -$18.77M
2,301,113 shares
$30.31M
RUBINSTEIN JULIE
President and COO
0 27 -$8.72M
447,202 shares
$6.53M
ROBINS HARLAN S
Chief Scientific Officer
0 9 -$8.22M
1,522,058 shares
$20.05M
LO FRANCIS
Chief People Officer
0 7 -$4.39M
291,374 shares
$4.10M
BENZENO SHARON
Chief Commercial Ofc Imm Med
0 2 -$1.04M
272,751 shares
$3.59M
GRIFFIN MICHELLE RENEE
DIRECTOR
0 2 -$949K
15,625 shares
$217K
BOBULSKY SUSAN
Chief Commercial Officer, MRD
0 1 -$544K
427,775 shares
$5.63M
HERSHBERG ROBERT
DIRECTOR
0 1 -$367K
46,722 shares
$748K
PISKEL KYLE
Chief Financial Officer
0 3 -$363K
259,840 shares
$3.42M

Recent Transactions

SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $14.60

$278K

Apr 2, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $14.45

$275K

Apr 1, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.45

$256K

Mar 31, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $12.63

$241K

Mar 30, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

16,322 shares @ $13.48

$220K

Mar 27, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

2,738 shares @ $12.49

$34K

Mar 27, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $14.12

$269K

Mar 26, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $14.27

$272K

Mar 25, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.70

$261K

Mar 24, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.83

$264K

Mar 23, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.37

$255K

Mar 20, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.18

$251K

Mar 19, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.18

$251K

Mar 18, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.40

$255K

Mar 17, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $13.41

$256K

Mar 16, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $12.96

$247K

Mar 13, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

13,660 shares @ $12.63

$173K

Mar 12, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

5,400 shares @ $13.43

$73K

Mar 12, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

329,600 shares @ $13.17

$4.34M

Mar 11, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

329,600 shares @ $13.17

$4.34M

Mar 11, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

140,666 shares @ $13.17

$1.85M

Mar 11, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

140,567 shares @ $13.17

$1.85M

Mar 11, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

122,523 shares @ $13.17

$1.61M

Mar 11, 2026

Conviction: | View SEC Filing →
SELL BENZENO SHARON (Chief Commercial Ofc Imm Med)

63,103 shares @ $13.17

$831K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL BOBULSKY SUSAN (Chief Commercial Officer, MRD)

41,338 shares @ $13.17

$544K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

30,593 shares @ $14.08

$431K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,060 shares @ $14.08

$268K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL PISKEL KYLE (Chief Financial Officer)

18,672 shares @ $13.17

$246K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL GRIFFIN MICHELLE RENEE (DIRECTOR)

15,394 shares @ $13.91

$214K

Mar 11, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

19,460 shares @ $14.68

$286K

Mar 10, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

30,941 shares @ $14.79

$458K

Mar 9, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

30,941 shares @ $15.14

$468K

Mar 6, 2026

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

38,074 shares @ $15.09

$575K

Mar 5, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

30,941 shares @ $16.00

$495K

Mar 5, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

30,941 shares @ $16.60

$514K

Mar 4, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

50,703 shares @ $15.49

$785K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL GRIFFIN MICHELLE RENEE (DIRECTOR)

48,044 shares @ $15.30

$735K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

24,423 shares @ $15.49

$378K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

14,233 shares @ $16.52

$235K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL RUBINSTEIN JULIE (President and COO)

6,518 shares @ $16.33

$106K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

2,380 shares @ $16.15

$38K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

289,024 shares @ $15.82

$4.57M

Mar 2, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

10,000 shares @ $15.72

$157K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

182,891 shares @ $15.99

$2.92M

Feb 27, 2026

Conviction: | View SEC Filing →
SELL PISKEL KYLE (Chief Financial Officer)

2,145 shares @ $18.46

$40K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

8,120 shares @ $19.00

$154K

Feb 3, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

124,998 shares @ $18.44

$2.30M

Feb 2, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

34,668 shares @ $18.60

$645K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

79,590 shares @ $17.73

$1.41M

Jan 12, 2026

Conviction: | View SEC Filing →
SELL PISKEL KYLE (Chief Financial Officer)

4,290 shares @ $18.00

$77K

Jan 12, 2026

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

10,000 shares @ $16.44

$164K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL ROBINS CHAD M (CEO and Chairman)

124,998 shares @ $15.59

$1.95M

Jan 5, 2026

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

3,125 shares @ $16.08

$50K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

4,394 shares @ $17.50

$77K

Dec 22, 2025

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

4,394 shares @ $17.50

$77K

Dec 22, 2025

Conviction: | View SEC Filing →
SELL LO FRANCIS (Chief People Officer)

113,890 shares @ $15.57

$1.77M

Dec 15, 2025

Conviction: | View SEC Filing →
SELL HERSHBERG ROBERT (DIRECTOR)

22,968 shares @ $16.00

$367K

Dec 10, 2025

Conviction: | View SEC Filing →
SELL BENZENO SHARON (Chief Commercial Ofc Imm Med)

12,604 shares @ $16.85

$212K

Dec 4, 2025

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

10,000 shares @ $16.61

$166K

Dec 4, 2025

Conviction: | View SEC Filing →
SELL ROBINS HARLAN S (Chief Scientific Officer)

27,212 shares @ $18.61

$506K

Dec 3, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.